In conclusion, this study demonstrates that SLC12A7 plays an important role in adrenal cancer by promoting tumor invasion, and as such, could represent a marker of tumor aggressiveness to serve as a potential therapeutic target. The gene discussed is SLC12A7; the disease is adrenal gland cancer.